Japan, Jan. 23 -- TRUEBINDING INC has got intellectual property rights for 'CANCER THERAPY BY BLOCKING INTERACTION BETWEEN TIM-3 AND ITS LIGAND.' Other related details are as follows:
Application Number: JP,2023-118382
Category (FI): A61K39/395@E,C07K14/705,C07K16/28,C12N15/13,G01N33/53@D,A61K9/16,A61K9/51,A61K39/395@T,A61K9/08,A61P43/00,121,A61K45/00,A61P35/04,A61P37/04,A61K39/395@D,C07K16/30,A61P35/00,A61K39/395@N,A61P43/00,111
Stage: Grant (IP right document published.)
Filing Date: July 20, 2023
Publication Date: Oct. 11, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....